Search Results 601-610 of 15723 for 3-day reset protocol

  1. Nivolumab and Brentuximab Vedotin After Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Classical Hodgkin Lymphoma - Mayo Clinic

    Phase 3 trials include large numbers of people to ... Sponsor Protocol Number: 16378. About ... Live vaccine within 30 days prior to day 1 of protocol ...

  2. Stress management Relaxation techniques - Mayo Clinic

    But many challenges daily ... Stress management gives you a range of tools to reset and to recalibrate your alarm system. ... But daily hassles and demands, such as ...

  3. A Study to Evaluate the Effectiveness, Safety, Pharmacokinetics and Pharmacodynamics of Idasanutlin Monotherapy in Participants With Hydroxyurea-Resistant/Intolerant Polycythemia Vera - Mayo Clinic

    Phase 3 trials include large numbers of people to ... Sponsor Protocol Number: NP39761. About this study ... Resistance to HU is defined at a dose ≥ 2 g/day or a ...

  4. A Study of ANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma (OMNIA-1) - Mayo Clinic

    Phase 3 trials include large numbers of people to ... Sponsor Protocol Number: ANV419-101. About this ... days prior to study Day 1; - Are receiving ...

  5. Short-Wave Near Infrared (SWIR) Imaging System For Characterizing Lymphatic Anatomy - Mayo Clinic

    Phase 3 trials include large numbers of people to ... Guidelines differ from ... Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

  6. SMRTAC pursues return to pre-COVID-19 participation and change in transfer guidelines - Mayo Clinic

    SMRTAC is undergoing a reorganization affecting practice guidelines for Level 3 and 4 trauma centers, all of which the state of Minnesota accredits. The ...

  7. Sudden death in young people: Heart problems often blamed - Mayo Clinic

    Type 3 or more letters to display suggested search options. ... It delivers shocks to reset the heart rhythm. No ... Guidelines and the Heart Rhythm Society.

  8. A Study to Evaluate the Effectiveness and Safety of Camidanlumab Tesirine (ADCT-301) in Patients with Relapsed or Refractory Hodgkin Lymphoma - Mayo Clinic

    Phase 3 trials include large numbers of people to ... Sponsor Protocol Number: ADCT-301-201. About this ... Negative beta-human chorionic gonadotropin (β-HCG) ...

  9. Digestive Diseases Clinical Trials - Medical Professionals

    The purpose of this study is to develop a biorepository of blood samples from cancer patients participating in the Gemini (IRB 19-006717) protocol. These ...

  10. Sick sinus syndrome - Diagnosis & treatment - Mayo Clinic

    Type 3 or more letters to display suggested search options. ... This portable ECG device can be worn for a day or more during daily activities. ... Most people with ...